Skip to content

Clinical trials

Expanded access trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Expanded access Country / region: Hong Kong Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20062
20081

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
No longer available6
Approved for marketing5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Pfizer2
Bayer1
Center Trials & Treatment1
Eisai Inc.1
Eli Lilly and Company1
Janssen-Cilag Farmaceutica Ltda.1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Novartis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms2
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Medullary1
Carcinoma, Renal Cell1
Colonic Neoplasms1
Gastrointestinal Neoplasms1
Genital Diseases, Male1
Genital Neoplasms, Male1
Glioblastoma1
Glioma1

Trials

Showing 76 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.